Drug Search Results
More Filters [+]

Cephalothin

Alternative Names: cephalothin, cefalotina, keflin in plastic container, keflin, seffin
Latest Update: 2021-10-08
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PBP Inhibitor,Cell Wall Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Bangladesh | Brazil | Chile | Colombia | Dominican Republic | India | Ireland | Italy | Mexico | Morocco | New Zealand | Pakistan | Peru | Russia | South Africa | Taiwan | Turkey | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Cabrini Research and Education Institute and Monash University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cephalothin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NEM-2011/2296

N/A

Unknown status

Femoral Fractures|Femoral Neck Fractures

2020-02-06

ACTRN12605000079640

N/A

Completed

Osteoporosis|Osteoporotic Fractures

2008-10-30

Recent News Events

Date

Type

Title